Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus

被引:150
作者
Feng, Bo [1 ]
Chen, Yinghua [1 ]
Luo, Yun [1 ]
Chen, Ming [2 ]
Li, Xu [1 ]
Ni, Yafang [1 ]
机构
[1] Tongji Univ, East Hosp, Dept Endocrinol, Shanghai 200120, Peoples R China
[2] Tongji Univ, East Hosp, Dept Ultrasound, Shanghai 200120, Peoples R China
关键词
Microparticle; Brachial ankle pulse wave velocity; Endothelium-dependent dilation; Type 2 diabetes mellitus; CELL-DERIVED MICROPARTICLES; LEUKOCYTE ACTIVATION; DYSFUNCTION; PLATELET; ATHEROSCLEROSIS; GENERATION;
D O I
10.1016/j.atherosclerosis.2009.06.037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study was designed to measure the circulating level of microparticles (MP) in patients with type 2 diabetes mellitus versus healthy volunteers and to evaluate their correlation with arterial elasticity and endothelium-dependent dilation. Methods: Flow cytometry was used to measure the circulating levels of MP, including annexinV+MP, platelet-derived microparticles (PMP), leukocyte-derived microparticles (LMP) and endothelial microparticles (EMP), in 63 patients with type 2 diabetes mellitus and 29 healthy volunteers. Brachial ankle pulse wave velocity (baPWV) and endothelium-dependent flow-mediated dilation (FMD) of the brachial artery were also measured. Results: The levels of annexinV+MP, PMP, LMP, CD31+/CD42-EMP and CD51+EMP increased significantly in diabetic patients compared with healthy controls (P < 0.001). Correlation analysis showed that HbA(1c) was positively correlated to CD31+/CD42-EMP (r(s) = 0.337, P = 0.008) and CD51+EMP (r(s) = 0.266, P = 0.038). FMD in diabetic patients was significantly lower than that in healthy individuals (P = 0.007). FMD was negatively correlated to CD31+/CD42-EMP (r(s) = -0.441, P = 0.008) and CD51+EMP (r(s) = -0.405, P = 0.016). baPWV level in diabetic patients was significantly higher than that in healthy individuals ( P < 0.001). baPWV was positively correlated to CD31+/CD42-EMP (r(s) = 0.497, P < 0.001) and CD51+EMP (r(s) = 0.428, P = 0.001). Multiple regression analysis indicated that EMP was an independent risk factor of FMD and baPWV. Conclusions: The circulating level of microparticles increases in patients with type 2 diabetes. The level of endothelial microparticles is closely associated with vascular dysfunction. (c) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:264 / 269
页数:6
相关论文
共 23 条
[1]   Enclothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome [J].
Agouni, Abdelali ;
Lagrue-Lak-Hal, Anne Helene ;
Ducluzeau, Pierre Henri ;
Mostefai, Hadj Ahmed ;
Draunet-Busson, Catherine ;
Leftheriotis, Georges ;
Heymes, Christophe ;
Martinez, Maria Carmen ;
Andriantsitohaina, Ramaroson .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (04) :1210-1219
[2]   Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome [J].
Arteaga, Roque B. ;
Chirinos, Julio A. ;
Soriano, Andres O. ;
Jy, Wenche ;
Horstman, Lawrence ;
Jimenez, Joaquin J. ;
Mendez, Armando ;
Ferreira, Alexandre ;
de Marchena, Eduardo ;
Ahn, Yeon S. .
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (01) :70-74
[3]   High levels of circulating endothelial microparticles in patients with acute coronary syndromes [J].
Bernal-Mizrachi, L ;
Jy, W ;
Jimenez, JJ ;
Pastor, J ;
Mauro, LM ;
Horstman, LL ;
de Marchena, E ;
Ahn, YS .
AMERICAN HEART JOURNAL, 2003, 145 (06) :962-970
[4]   Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT) [J].
Bernard, Sophie ;
Loffroy, Romaric ;
Serusclat, Andre ;
Boussel, Loic ;
Bonnefoy, Eric ;
Thevenon, Chantal ;
Rabilloud, Muriel ;
Revel, Didier ;
Moulin, Philippe ;
Douek, Philippe .
ATHEROSCLEROSIS, 2009, 203 (02) :429-435
[5]   Microparticle-mediated thrombin generation assay: increased activity in patients with recurrent thrombosis [J].
Bidot, L. ;
Jy, W. ;
Bidot, C. ;
Jimenez, J. J. ;
Fontana, V. ;
Horstman, L. L. ;
Ahn, Y. S. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (06) :913-919
[6]   Endothelium-derived microparticles impair endothelial function in vitro [J].
Brodsky, SV ;
Zhang, F ;
Nasjletti, A ;
Goligorsky, MS .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 286 (05) :H1910-H1915
[7]   Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism [J].
Chirinos, JA ;
Heresi, GA ;
Velasquez, H ;
Jy, W ;
Jimenez, JJ ;
Ahn, E ;
Horstman, LL ;
Soriano, AO ;
Zambrano, JP ;
Ahn, YS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (09) :1467-1471
[8]   Circulating leukocyte-derived microparticles predict subclinical atherosclerosis burden in asymptomatic subjects [J].
Chironi, Gilles ;
Simon, Alain ;
Hugel, Benedicte ;
Del Pino, Muriel ;
Gariepy, Jerome ;
Freyssinet, Jean-Marie ;
Tedgui, Alain .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (12) :2775-2780
[9]   In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant [J].
Combes, V ;
Simon, AC ;
Grau, GE ;
Arnoux, D ;
Camoin, L ;
Sabatier, F ;
Mutin, M ;
Sanmarco, M ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) :93-102
[10]   Role of endothelial dysfunction in atherosclerosis [J].
Davignon, J ;
Ganz, P .
CIRCULATION, 2004, 109 (23) :27-32